Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19

JAMA Netw Open. 2021 Mar 1;4(3):e211091. doi: 10.1001/jamanetworkopen.2021.1091.

Abstract

This cohort study analyzed inpatient data from multiple US hospitals to characterize patients with and without coronavirus disease (COVID-19) who had diabetic ketoacidosis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acid-Base Equilibrium
  • Acute Kidney Injury / epidemiology
  • Adult
  • Age Distribution
  • Age Factors
  • Aged
  • Blood Glucose / metabolism
  • COVID-19 / complications
  • COVID-19 / epidemiology*
  • Cardiovascular Diseases / epidemiology
  • Case-Control Studies
  • Comorbidity
  • Diabetes Complications / epidemiology
  • Diabetic Ketoacidosis / complications
  • Diabetic Ketoacidosis / drug therapy
  • Diabetic Ketoacidosis / metabolism
  • Diabetic Ketoacidosis / mortality*
  • Female
  • Glycated Hemoglobin / metabolism
  • Hospital Mortality*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Obesity / epidemiology
  • SARS-CoV-2
  • United States / epidemiology

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • hemoglobin A1c protein, human